Heading: |
|
Question ID: |
1813015 |
UIN: |
59994 |
House: |
Commons |
Date tabled: |
2025-06-16 |
Asking Member ID: |
1409 |
Asking Member display name: |
Mr Gregory Campbell
|
Asking Member handle: |
|
Asking Member Twitter reference: |
Mr Gregory Campbell
|
Member interest: |
false |
Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 May 2025 to Question 52196 on Prostate Cancer: Preventive Medicine, when he expects to receive the outcome of UK NSCs comprehensive evidence review. |
Is named day: |
true |
Date of holding answer: |
|
Date answered: |
2025-06-19 |
Date answer corrected: |
|
Is holding answer: |
false |
Is correcting answer: |
false |
Answering Member ID: |
4981 |
Answering Member display name: |
Ashley Dalton
|
Answering Member handle: |
AshleyDalton_MP
|
Answering Member Twitter reference: |
@AshleyDalton_MP
|
Correcting Member ID: |
|
Correcting Member display name: |
|
Correcting Member handle: |
|
Correcting Member Twitter reference: |
|
Answer text: |
The UK National Screening Committee (UK NSC) has commissioned work to update its recommendation on population screening for prostate cancer screening last made in 2020. The review this time round however has been expanded in response to calls to consider ... |
Original answer text: |
|
Comparable answer text: |
|
Answering body ID: |
17 |
Answering body name: |
Department of Health and Social Care |
Tweeted: |
true |